Error: Could not add to watchlist. X

Inovio Pharmaceuticals Inc

+ Watchlist
INO:US
NASDAQ GS
8.42
USD
0.08
0.96%
As of 20:10:00 ET on 06/02/2015.
Open
8.36
Day Range
8.25 - 8.57
Volume
614,060
Previous Close
8.34
52Wk Range
6.33 - 14.20
1 Yr Return
-7.68%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.60
Market Cap (m USD)
604.642
Shares Outstanding (m)
71.810
Price/Sales (TTM)
38.43
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Inovio Pharmaceuticals, Inc. researches and develops pharmaceuticals. The Company develops cancer DNA and infectious DNA vaccines, anti-inflammatory drugs, and animal health products.
ADDRESS
1787 Sentry Parkway West
Building 18, Suite 400
Blue Bell, PA 19422
United States
PHONE
1-267-440-4200
  • J Joseph Kim
    President/CEO
  • Peter D Kies
    Chief Financial Officer
  • Niranjan Y Sardesai
    Chief Operating Officer
  • Mark L Bagarazzi
    Chief Medical Officer
  • Bernie Hertel
    VP:Investor Relations
Show More